Craniofacial and axial skeletal defects induced by the fungicide triadimefon in the mouse
- 15 April 2005
- journal article
- research article
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 74 (2) , 185-195
Abstract
BACKGROUND: Triadimefon is an antifungal derived from triazole. In in vitro whole‐rodent embryo cultures, triazole‐derivatives showed specific teratogenic effects at the branchial apparatus. The aim of the present work was to test in vivo triadimefon (FON), in order to verify a relationship between triazole exposure, embryonic abnormalities, and/or fetal malformations. METHODS: Pregnant CD‐1 mice were treated with 0–300 mg/kg FON by gavage on day 8 post coitum (p.c.) at 10:00 AM, and sacrificed on day 8 p.c. at 1:00 PM, on day 9 p.c. at 10:00 AM, on day 10 p.c. at 10:00 AM, and at term of gestation (day 18 p.c.). At midgestation, the embryos were processed for specific immunostainings to visualize the hindbrain segmentation (day 8 p.c.) and the neural crest cell migration (days 8 and 9 p.c.). Fetuses explanted at term were all processed for skeletal examination after double‐staining of osseous and cartilaginous tissues. RESULTS: At midgestation, the immunostaining of rhombomeres 3 and 5 showed a light scattering of the immunostained areas; the neural crest cell migration was unaffected, but their localization at the branchial arch level was abnormal. At term, several severe malformations were observed at the craniofacial and at the axial skeletal level. Ectopic cartilage was observed at the upper jaw. CONCLUSIONS: Triadimefon is teratogenic. The observed craniofacial malformations could be explained by an alteration of the rhombomeric organization and neural crest migration to the branchial arches; the axial abnormalities could be explained by the abnormal segmental identity specification. Birth Defects Res B 74:185–195, 2005.Keywords
This publication has 36 references indexed in Scilit:
- Methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis, and cervical vertebral malformations in C57BL/6J miceBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2004
- Atlas of rat fetal skeleton double stained for bone and cartilageTeratology, 2001
- Pathogenesis of retinoic acid-induced ear malformations in a primate modelTeratology, 1999
- Fluconazole teratogenicityPrenatal Diagnosis, 1998
- Retinoid-Regulated Gene Expression in Neural DevelopmentCritical Reviews™ in Eukaryotic Gene Expression, 1997
- Fluconazole inCandida albicans sepsis during pregnancy: Case report and review of the literatureInfection, 1996
- CONGENITAL MALFORMATIONS IN AN INFANT BORN TO A WOMAN TREATED WITH FLUCONAZOLEThe Pediatric Infectious Disease Journal, 1992
- Fluconazole: A Potent Inhibitor of Cytochrome P-450-Dependent Drug-Metabolism in Mice and Humans in Vivo. Comparative Study with Ketoconazole.Chemical and Pharmaceutical Bulletin, 1992
- Craniofacial dysmorphogenesis following hypervitaminosis A in miceTeratology, 1987
- A Rapid Procedure for Routine Double Staining of Cartilage and Bone in Fetal and Adult AnimalsStain Technology, 1981